Non-Segmental Vitiligo
Non-Segmental Vitiligo is a skin condition where patches of skin lose their pigment, leading to lighter areas on the skin. It can affect any part of the body and may be associated with other autoimmune conditions.
Nonsegmental Vitiligo: Ritlecitinib Study
We are investigating the safety and effectiveness of ritlecitinib in adults and adolescents with nonsegmental vitiligo. This study looks at how well the medication works over time for those who have already been treated.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 18 years old or older?
- Do you have any active suicidal thoughts or behaviors?
- Have you had a severe allergic reaction to any medications or treatments?
- Are you currently using any other treatments for vitiligo?
- Have you had any major health issues that would make you unsuitable for a study, like a serious illness or surgery planned?
What experimental substances are being tested?
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Ritlecitinib
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
Umbal - Prof. D-R Stoyan Kirkovich AD
Dermatology and Venerology
Kardzhali, Bulgaria
Diagnostic-Consultative Center Alexandrovska EOOD
Dermatology
Sofia, Bulgaria
Diagnostic-Consultative Center Alexandrovska EOOD
Dermatology
Sofia, Bulgaria
Sponsor: Pfizer Inc.
Last updated: Nov 27, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.